Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
about
Stem cell therapy for heart failure: Ensuring regenerative proficiencyMeta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease.Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy.Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trialOverexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial InfarctionCongestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN TrialAdult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.Cellular Therapy for Heart Failure.Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease.Response to letter regarding article, "a detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b and clonogenic capacity as biomarkers for clinical outcomes".Erythroblast macrophage protein (Emp): Past, present, and future.Expression of Matrix Metalloproteinase-9 and CD34 in Giant Cell Tumor of Bone.Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.Cardiopoietic index predicts heart repair fitness of patient-derived stem cells.
P2860
Q26750516-23FF8C33-9800-454B-80D1-257631F15775Q30896351-40F651E7-4B92-4A6A-8086-71667B07C5E2Q35887279-4E54AA29-EEEF-44C2-A0D0-E7477E650B72Q36008423-33509BAC-19A5-4579-81D4-423EC662D0D3Q36123176-840A37B9-71B8-4F78-A9FB-1770A68D1045Q36877532-449F9C98-AECE-461A-A81B-2B8E70605FD6Q37340293-A3035DFA-4F60-46BB-BD30-8C4624C43554Q37383093-448B40CC-2860-4076-B217-4A8F7CE3566EQ37698929-389962A5-7DE7-43DB-B67E-A9ABBCB69BB6Q37738591-C5A18E47-A84C-4808-8C05-6D04D77091E7Q38338199-3E3BDCA6-D910-4864-A185-40C42E904A2CQ38376997-47B057E6-6B8E-4D3B-A2B8-82AFB186E80BQ38859871-DEEAF915-F9CC-4DC1-8674-2DFE755431FCQ40600315-4C249F71-3E71-4AF1-A5C2-CB15EBA22658Q43058119-62521352-4FC8-4FD9-8CD6-3BE3CBB17CF2Q45982253-85AFA3D6-1009-40D5-BBD9-20BF5568F0DAQ47614214-65B4238A-E1E5-430C-BB6B-ABB34AB17C06Q49171170-8F5016B6-99B7-4B70-8BCD-D13DEE4F32F9Q52940712-41D681F3-09BD-4FE1-A525-09E7C96B5019
P2860
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Detailed analysis of bone marr ...... markers for clinical outcomes.
@ast
Detailed analysis of bone marr ...... markers for clinical outcomes.
@en
type
label
Detailed analysis of bone marr ...... markers for clinical outcomes.
@ast
Detailed analysis of bone marr ...... markers for clinical outcomes.
@en
prefLabel
Detailed analysis of bone marr ...... markers for clinical outcomes.
@ast
Detailed analysis of bone marr ...... markers for clinical outcomes.
@en
P2093
P2860
P50
P1433
P1476
Detailed analysis of bone marr ...... omarkers for clinical outcomes
@en
P2093
Amy M Meacham
Aruni Bhatnagar
Cardiovascular Cell Therapy Research Network (CCTRN)
Christopher R Cogle
Claudia Zierold
David X M Zhao
Dejian Lai
Doris A Taylor
Edward W Scott
Elizabeth Wise
P2860
P304
P356
10.1161/CIRCRESAHA.115.304353
P577
2014-08-18T00:00:00Z